Nienke de Glas (@nienkedeglas) 's Twitter Profile
Nienke de Glas

@nienkedeglas

MD | PhD in Geriatric Oncology | Clinical Epidemiologist | Veni Recipient | Fellow in Oncology / Internal Medicine

ID: 619853293

calendar_today27-06-2012 09:50:09

875 Tweet

510 Followers

290 Following

Nienke de Glas (@nienkedeglas) 's Twitter Profile Photo

I assume this was a first: having a rheumatologist speaking at SIOG! Very valuable insights in treatment of irAEs. #SIOG2022

Nienke de Glas (@nienkedeglas) 's Twitter Profile Photo

Big data is promising for studying outcome in older adults as presented by Dr. Sophie Pilleron. But importantly: large ≠ good. Bias still occurs in large databases so having a methodologist on board is essential in my opinion.

Big data is promising for studying outcome in older adults as presented by <a href="/SPilleron/">Dr. Sophie Pilleron</a>. But importantly: large ≠ good. Bias still occurs in large databases so having a methodologist on board is essential in my opinion.
Annelieke Lemij (@aalemij) 's Twitter Profile Photo

Our poster at #EBCC13 on psychological outcomes in older women with breast cancer; nearly half of all patients have apathy in the years after diagnosis Nienke de Glas johanneke portielje

Our poster at #EBCC13 on psychological outcomes in older women with breast cancer; nearly half of all patients have apathy in the years after diagnosis <a href="/NienkedeGlas/">Nienke de Glas</a> <a href="/JoPortielje/">johanneke portielje</a>
Joosje Baltussen (@jcbaltussen) 's Twitter Profile Photo

🇳🇱 Treatment/survival of Dutch older patients with metastatic colorectal cancer rapidly changed from 2005 to 2020: 📈 more best supportive care 📉 less chemotherapy 🔴 decreased survival since '14 onlinelibrary.wiley.com/doi/10.1002/ij… International Journal of Cancer Nienke de Glas @DrSimonPM johanneke portielje

🇳🇱 Treatment/survival of Dutch older patients with  metastatic colorectal cancer rapidly changed from 2005 to 2020:
📈 more best supportive care
📉 less chemotherapy
🔴 decreased survival since '14
onlinelibrary.wiley.com/doi/10.1002/ij…
<a href="/IntJCanc/">International Journal of Cancer</a> <a href="/NienkedeGlas/">Nienke de Glas</a> @DrSimonPM <a href="/JoPortielje/">johanneke portielje</a>
Annelieke Lemij (@aalemij) 's Twitter Profile Photo

More research into high-risk tumours and integration of geriatric characteristics is needed before gene expression signatures can be implemented as a prediction tool for adjuvant chemotherapy decision-making in #olderwomen with #breastcancer pubmed.ncbi.nlm.nih.gov/36442749/ Critical Reviews in Oncology Hematology (CROH)

Joosje Baltussen (@jcbaltussen) 's Twitter Profile Photo

🧠Cognition of older women with early breast cancer using ET did NOT decline after 2 years 🔍Even in the frailest patients: no meaningful decline Check out our latest article in EJC: ejcancer.com/article/S0959-… Annelieke Lemij johanneke portielje @DrSimonPM Nienke de Glas

🧠Cognition of older women with early breast cancer using ET did NOT decline after 2 years
🔍Even in the frailest patients: no meaningful decline

Check out our latest article in EJC:
ejcancer.com/article/S0959-…
<a href="/aalemij/">Annelieke Lemij</a> <a href="/JoPortielje/">johanneke portielje</a> @DrSimonPM <a href="/NienkedeGlas/">Nienke de Glas</a>
Annelieke Lemij (@aalemij) 's Twitter Profile Photo

Happy to share our latest article in #TheOncologist, highlighting the need for careful evaluation of older patients with breast cancer: geriatric characteristics, loneliness, and depressive symptoms were associated with physical decline, while breast cancer treatment was not

Happy to share our latest article in #TheOncologist, highlighting the need for careful evaluation of older patients with breast cancer: geriatric characteristics, loneliness, and depressive symptoms were associated with physical decline, while breast cancer treatment was not
Dr. Sophie Pilleron (@spilleron) 's Twitter Profile Photo

👋🏻 there, I am hiring a #PhD student with skills in quantitative (and qualitative) methods to work with me LIH_Luxembourg on access to #cancer diagnosis and care in #olderadults thanks to Luxembourg National Research Fund (FNR) funding 🤗 careers.lih.lu/jobs/detail/ph… 📩me for more info

Joosje Baltussen (@jcbaltussen) 's Twitter Profile Photo

Nienke de Glas presenting about ICIs in older patients @ the Ed Maartense #symposium ➡️Frail older patients more ofted experience grade 1-2 tox & hospitalizations after ICIs ➡️the G8 can help identifying frail patients

<a href="/NienkedeGlas/">Nienke de Glas</a> presenting about ICIs in older patients @ the Ed Maartense #symposium

➡️Frail older patients more ofted experience grade 1-2 tox &amp; hospitalizations after ICIs
➡️the G8 can help identifying frail patients
Nienke de Glas (@nienkedeglas) 's Twitter Profile Photo

Very proud to announce that we received funding to perform our phase III Dosage trial on dose reduced chemotherapy in older adults! #GeriOnc kwf.nl/nieuws/toekenn…

Nienke de Glas (@nienkedeglas) 's Twitter Profile Photo

We just had an incredible kickoff meeting by the siog methods group, hosted by Dr. Sophie Pilleron and Jennifer Lund. Looking forward to working on improving research methods in #GeriOnc!

Joosje Baltussen (@jcbaltussen) 's Twitter Profile Photo

🎉We have received funding from KWFKankerbestrijding for a large randomized trial investigating upfront dose-reduced #chemotherapy in #older patients with metastatic colorectal cancer! 🎉 Nienke de Glas johanneke portielje LUMC Leiden #LUMC leidenlifecoursegeroscience.nl/kwf-grant-for-…

LUMC Leiden (@lumc_leiden) 's Twitter Profile Photo

Vier onderzoeksgroepen in het LUMC krijgen in totaal 2,75 miljoen euro subsidie van KWF Kankerbestrijding. Met de toegekende bedragen gaan de onderzoeksgroepen aan de slag met projecten die bijdragen aan een beter leven voor kankerpatiënten. Lees meer 👉 ap.lc/zrqRr

Vier onderzoeksgroepen in het LUMC krijgen in totaal 2,75 miljoen euro subsidie van KWF Kankerbestrijding. Met de toegekende bedragen gaan de onderzoeksgroepen aan de slag met projecten die bijdragen aan een beter leven voor kankerpatiënten. Lees meer 👉 ap.lc/zrqRr
Enrique Soto (@enriquesoto8) 's Twitter Profile Photo

FANTASTIC and practice changing trial from the Netherlands, SONIA shows that CDK4/6i in 2nd line are as effective as in 1st line with less Toxicity and cost. This is what happens when you ask right questions and design studies to benefit patients instead of companies. #ASCO23

FANTASTIC and practice changing trial from the Netherlands, SONIA shows that CDK4/6i in 2nd line are as effective as in 1st line with less Toxicity and cost.
This is what happens when you ask right questions and design studies to benefit patients instead of companies. #ASCO23
Nienke de Glas (@nienkedeglas) 's Twitter Profile Photo

Finally!! After 18 years of medical school, PhD, residency, postdoc and a fellowship, I can call myself a Medical Oncologist :)! Now preparing a big move to Norway with my family.